Hong Tao

Survival of patients with advanced non-small cell lung cancer harboring different ROS1 fusion subtypes: a real-world study

Abstract Background c-ros oncogene 1 (ROS1) rearrangement is a rare yet significant genetic abnormality in non-small cell lung cancer. However, real-world treatment data for Non-Small Cell Lung Cancer (NSCLC) patients with different ROS1 fusion subtypes remain limited. Methods Me...